Tower Research Capital LLC (TRC) - CORREVIO PHARMA CORP ownership

Back to all holdings Add to watchlist

CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 40 filers reported holding CORREVIO PHARMA CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CORREVIO PHARMA CORP
ValueSharesWeighting
Q3 2019$3,000
-40.0%
1,171
-29.1%
0.00%–
Q1 2019$5,000
-16.7%
1,652
-28.6%
0.00%–
Q4 2018$6,0000.0%2,313
+67.2%
0.00%–
Q3 2018$6,000–1,383–0.00%–
 Download
Other shareholders

There were no reported owners of CORREVIO PHARMA CORP in Q3 2019.

NameSharesValueWeighting ↓
View complete list of CORREVIO PHARMA CORP shareholders